These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12151116)

  • 21. [Personalized medicine for epilepsy based on the pharmacogenomic testing].
    Yoshida S; Sugawara T; Nishio T; Kaneko S
    Brain Nerve; 2011 Apr; 63(4):295-9. PubMed ID: 21441631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety of treating newly diagnosed epilepsy.
    Sharma S; Kwan P
    Expert Opin Drug Saf; 2019 Apr; 18(4):273-283. PubMed ID: 30943798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The new antiepileptic drugs: their indications and side effects].
    Malagón-Valdez J
    Rev Neurol; 2004 Sep 16-30; 39(6):570-5. PubMed ID: 15467997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of antiepileptic drugs in the era of pharmacogenomics: A focus on childhood.
    Gogou M; Pavlou E
    Eur J Paediatr Neurol; 2019 Sep; 23(5):674-684. PubMed ID: 31280948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy of epilepsy: new armamentarium, new issues.
    Vajda FJ
    J Clin Neurosci; 2007 Sep; 14(9):813-23. PubMed ID: 17618119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of common variation in drug transporter genes in refractory epilepsy.
    Soranzo N; Goldstein DB; Sisodiya SM
    Expert Opin Pharmacother; 2005 Jul; 6(8):1305-12. PubMed ID: 16013981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs.
    Meldrum B
    Epilepsy Res; 2002 Jun; 50(1-2):33-40. PubMed ID: 12151115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New strategies for the identification of drugs to prevent the development or progression of epilepsy.
    Schmidt D; Rogawski MA
    Epilepsy Res; 2002 Jun; 50(1-2):71-8. PubMed ID: 12151119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview.
    Ferraro TN; Buono RJ
    Epilepsy Behav; 2005 Aug; 7(1):18-36. PubMed ID: 15979945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical impact of pharmacogenetics on the treatment of epilepsy.
    Löscher W; Klotz U; Zimprich F; Schmidt D
    Epilepsia; 2009 Jan; 50(1):1-23. PubMed ID: 18627414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Search for New Screening Models of Pharmacoresistant Epilepsy: Is Induction of Acute Seizures in Epileptic Rodents a Suitable Approach?
    Löscher W
    Neurochem Res; 2017 Jul; 42(7):1926-1938. PubMed ID: 27502939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacogenomics of valproic acid.
    Zhu MM; Li HL; Shi LH; Chen XP; Luo J; Zhang ZL
    J Hum Genet; 2017 Dec; 62(12):1009-1014. PubMed ID: 28878340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis.
    Chouchi M; Kaabachi W; Klaa H; Tizaoui K; Turki IB; Hila L
    BMC Neurol; 2017 Feb; 17(1):32. PubMed ID: 28202008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between ABCB1 polymorphisms and response to first-generation antiepileptic drugs in a Tunisian epileptic population.
    Ajmi M; Boujaafar S; Zouari N; Amor D; Nasr A; Rejeb NB; Amor SB; Omezzine A; Benammou S; Bouslama A
    Int J Neurosci; 2018 Aug; 128(8):705-714. PubMed ID: 29198163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
    Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
    Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs.
    Reife RA
    Adv Neurol; 1998; 76():95-103. PubMed ID: 9408466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis.
    Haerian BS; Roslan H; Raymond AA; Tan CT; Lim KS; Zulkifli SZ; Mohamed EH; Tan HJ; Mohamed Z
    Seizure; 2010 Jul; 19(6):339-46. PubMed ID: 20605481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic animal models of epilepsy as a unique resource for the evaluation of anticonvulsant drugs. A review.
    Löscher W
    Methods Find Exp Clin Pharmacol; 1984 Sep; 6(9):531-47. PubMed ID: 6439966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics of KCNQ channel activation in 2 potassium channelopathy mouse models of epilepsy.
    Vanhoof-Villalba SL; Gautier NM; Mishra V; Glasscock E
    Epilepsia; 2018 Feb; 59(2):358-368. PubMed ID: 29265344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.